硬膜外导管原位患者皮下注射 40 毫克依诺肝素 24 小时后的预防范围抗因子 Xa 活性。

{"title":"硬膜外导管原位患者皮下注射 40 毫克依诺肝素 24 小时后的预防范围抗因子 Xa 活性。","authors":"Piotr F Czempik","doi":"10.5114/ait.2024.136863","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7750,"journal":{"name":"Anaesthesiology intensive therapy","volume":"56 1","pages":"86-88"},"PeriodicalIF":1.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022631/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prophylactic range anti-factor Xa activity 24 hours after subcutaneous injection of 40 mg of enoxaparin in a patient with an epidural catheter in situ.\",\"authors\":\"Piotr F Czempik\",\"doi\":\"10.5114/ait.2024.136863\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7750,\"journal\":{\"name\":\"Anaesthesiology intensive therapy\",\"volume\":\"56 1\",\"pages\":\"86-88\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022631/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anaesthesiology intensive therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/ait.2024.136863\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anaesthesiology intensive therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ait.2024.136863","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}